{{Rsnum
|rsid=2530215
|Gene=CTNND2
|Chromosome=5
|position=11298111
|Orientation=plus
|GMAF=0.4105
|Gene_s=CTNND2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 22.1 | 38.9 | 38.9
| HCB | 8.1 | 38.2 | 53.7
| JPT | 0.9 | 25.7 | 73.5
| YRI | 27.2 | 48.3 | 24.5
| ASW | 33.3 | 49.1 | 17.5
| CHB | 8.1 | 38.2 | 53.7
| CHD | 8.3 | 32.4 | 59.3
| GIH | 12.0 | 43.0 | 45.0
| LWK | 23.6 | 52.7 | 23.6
| MEX | 25.9 | 51.7 | 22.4
| MKK | 25.6 | 51.3 | 23.1
| TSI | 26.5 | 51.0 | 22.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=20889312
  |Trait=Bipolar disorder and schizophrenia
  |Title=A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder.
  |RiskAllele=
  |Pval=7E-6
  |OR=1.22
  |ORtxt=[NR]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}